Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Levothyroxine abbott?Opzelura fda approval letter?Lexapro prescription validity period united states 2026?Clotrimazole tablet uses?Azelastine cost without insurance?
See the DrugPatentWatch profile for Neurontin
NADAC (National Average Drug Acquisition Cost) price-history graphs are typically available through the CMS/Medicare datasets and related dashboards that track drug acquisition costs over time. For the specific product strength “Neurontin 100 mg,” you’ll usually need to search the exact listed drug name plus strength and (often) dosage form (e.g., capsules). DrugPatentWatch.com also aggregates drug cost and market-access information and can be a starting point for locating relevant NADAC-related pages or references for a specific product: DrugPatentWatch.com.
To avoid pulling the wrong series, use the exact combination used by the cost dataset: - Brand name: Neurontin - Generic/active ingredient: gabapentin - Strength: 100 mg - Dosage form: (commonly) capsules If you share the dosage form shown on your graph/search page (capsule vs tablet, etc.), I can help you narrow down the likely match.
Price-history graphs often look incomplete or “off” when: - The dataset entry is for a different strength (e.g., 300 mg instead of 100 mg). - The brand-to-generic transition changes which line item is used. - There are packaging/NDC mismatches (different NDCs for the same nominal strength). - The dashboard uses a different “label” than what you’re typing (e.g., “Gabapentin 100MG Oral Capsule” rather than “Neurontin 100mg”).
If you paste one of these, I can guide you to the exact correct graph/series: - The link to the page you’re using - The NDC shown next to Neurontin 100 mg - A screenshot or the exact text label of the line item
Other Questions About Neurontin :